Literature DB >> 11072901

Characterization, cloning and immunogenicity of antigens released by transforming cercariae of Schistosoma mansoni.

R Harrop1, N Jennings, A P Mountford, P S Coulson, R A Wilson.   

Abstract

A schistosome infection is initiated when the parasite penetrates the skin of a susceptible host. Relatively large quantities of protein are released by transforming cercariae compared to later larval stages. This represents the first parasite material to which the host's immune system is exposed, yet little is known about the proteins which are released during the first few hours post-transformation. We have shown that antiserum raised against such molecules was capable of imparting protection against a schistosome challenge infection upon passive transfer to naïve mice. By screening a cercarial cDNA library with this serum, 38 positive clones were identified. Sequence analysis showed these to represent 8 different molecules which included Schistosoma mansoni 21-7 kDa antigen, calcium-binding-protein and the vaccine candidate glutathione S-transferase (Sm28GST). In addition, 5 clones were isolated, 1 of which had significant homology to many cytochrome C proteins, another with leukocyte elastase inhibitors and 3 which represented novel molecules. Four clones were expressed in a prokaryotic high-level expression vector, sera produced against each purified recombinant protein and used subsequently to probe Western blots and parasite sections. The leukocyte elastase inhibitor homologue and 2 unknowns induced significant proliferation by lymph node cells recovered from mice vaccinated with irradiated cercariae. More strikingly, the 2 novel proteins stimulated very high levels of interferon gamma (IFNgamma) secretion both by lymph node cells and those recovered by broncho-alveolar lavage from the lungs of vaccinated mice. Such results will be discussed in the context of vaccine development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11072901     DOI: 10.1017/s003118209900640x

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  10 in total

1.  Screening the Schistosoma mansoni transcriptome for genes differentially expressed in the schistosomulum stage in search for vaccine candidates.

Authors:  Leonardo P Farias; Cibele A Tararam; Patricia A Miyasato; Milton Y Nishiyama; Katia C Oliveira; Toshie Kawano; Sergio Verjovski-Almeida; Luciana Cezar de Cerqueira Leite
Journal:  Parasitol Res       Date:  2010-09-18       Impact factor: 2.289

2.  Expression profile, localization of an 8-kDa calcium-binding protein from Schistosoma japonicum (SjCa8), and vaccine potential of recombinant SjCa8 (rSjCa8) against infections in mice.

Authors:  Zhi-Yue Lv; Lin-Lin Yang; Shao-Min Hu; Xi Sun; Han-Jiang He; Si-Jie He; Zheng-Yu Li; Yan-Ping Zhou; Ming-Chiu Fung; Xin-Bing Yu; Huan-Qin Zheng; Ai-Lian Cao; Zhong-Dao Wu
Journal:  Parasitol Res       Date:  2008-11-18       Impact factor: 2.289

3.  Schistosome serine protease inhibitors: parasite defense or homeostasis?

Authors:  Landys A Lopez Quezada; James H McKerrow
Journal:  An Acad Bras Cienc       Date:  2011-06       Impact factor: 1.753

4.  Cellular and humoral immune responses and protection against schistosomes induced by a radiation-attenuated vaccine in chimpanzees.

Authors:  M Eberl; J A Langermans; P A Frost; R A Vervenne; G J van Dam; A M Deelder; A W Thomas; P S Coulson; R A Wilson
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

5.  A blood fluke serine protease inhibitor regulates an endogenous larval elastase.

Authors:  Landys A Lopez Quezada; Mohammed Sajid; Kee C Lim; James H McKerrow
Journal:  J Biol Chem       Date:  2011-12-15       Impact factor: 5.157

6.  Dynamics of serological responses to defined recombinant proteins during Schistosoma mansoni infection in mice before and after the treatment with praziquantel.

Authors:  Eman Sayed Mohammed; Risa Nakamura; Yombo Dj Kalenda; Sharmina Deloer; Taeko Moriyasu; Mio Tanaka; Yoshito Fujii; Satoshi Kaneko; Kenji Hirayama; Ahmed I Ibrahim; Mahmoud A El-Seify; Asmaa M Metwally; Shinjiro Hamano
Journal:  PLoS Negl Trop Dis       Date:  2020-09-11

7.  An immunomics approach to schistosome antigen discovery: antibody signatures of naturally resistant and chronically infected individuals from endemic areas.

Authors:  Soraya Gaze; Patrick Driguez; Mark S Pearson; Tiago Mendes; Denise L Doolan; Angela Trieu; Donald P McManus; Geoffrey N Gobert; Maria Victoria Periago; Rodrigo Correa Oliveira; Fernanda C Cardoso; Guilherme Oliveira; Rie Nakajima; Al Jasinskas; Chris Hung; Li Liang; Jozelyn Pablo; Jeffrey M Bethony; Philip L Felgner; Alex Loukas
Journal:  PLoS Pathog       Date:  2014-03-27       Impact factor: 6.823

8.  Stage and tissue expression patterns of Schistosoma mansoni venom allergen-like proteins SmVAL 4, 13, 16 and 24.

Authors:  Rafaela Sachetto Fernandes; Tereza Cristina Barbosa; Mayra Mara Ferrari Barbosa; Patrícia Aoki Miyasato; Eliana Nakano; Luciana Cezar Cerqueira Leite; Leonardo Paiva Farias
Journal:  Parasit Vectors       Date:  2017-05-08       Impact factor: 3.876

Review 9.  Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity.

Authors:  James P Hewitson; John R Grainger; Rick M Maizels
Journal:  Mol Biochem Parasitol       Date:  2009-05-03       Impact factor: 1.759

Review 10.  Why the radiation-attenuated cercarial immunization studies failed to guide the road for an effective schistosomiasis vaccine: A review.

Authors:  Rashika El Ridi; Hatem Tallima
Journal:  J Adv Res       Date:  2014-10-20       Impact factor: 10.479

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.